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Abstract
Stoichiometric models of metabolism, such as flux balance analysis (FBA), are classically applied to predicting steady state
rates - or fluxes - of metabolic reactions in genome-scale metabolic networks. Here we revisit the central assumption of FBA,
i.e. that intracellular metabolites are at steady state, and show that deviations from flux balance (i.e. flux imbalances) are
informative of some features of in vivo metabolite concentrations. Mathematically, the sensitivity of FBA to these flux
imbalances is captured by a native feature of linear optimization, the dual problem, and its corresponding variables, known
as shadow prices. First, using recently published data on chemostat growth of Saccharomyces cerevisae under different
nutrient limitations, we show that shadow prices anticorrelate with experimentally measured degrees of growth limitation
of intracellular metabolites. We next hypothesize that metabolites which are limiting for growth (and thus have very
negative shadow price) cannot vary dramatically in an uncontrolled way, and must respond rapidly to perturbations. Using a
collection of published datasets monitoring the time-dependent metabolomic response of Escherichia coli to carbon and
nitrogen perturbations, we test this hypothesis and find that metabolites with negative shadow price indeed show lower
temporal variation following a perturbation than metabolites with zero shadow price. Finally, we illustrate the broader
applicability of flux imbalance analysis to other constraint-based methods. In particular, we explore the biological
significance of shadow prices in a constraint-based method for integrating gene expression data with a stoichiometric
model. In this case, shadow prices point to metabolites that should rise or drop in concentration in order to increase
consistency between flux predictions and gene expression data. In general, these results suggest that the sensitivity of
metabolic optima to violations of the steady state constraints carries biologically significant information on the processes
that control intracellular metabolites in the cell.
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Introduction
Cells endure relentless variations in intra- and extra-cellular
conditions. These perturbations propagate through the cell’s
metabolic and regulatory networks, leading to a diverse range of
interdependent, transient responses in the abundance of metab-
olites, transcripts, and proteins [1–3]. In spite of these changing
conditions, cells must efficiently allocate molecular resources
through the metabolic network to guarantee homeostasis and
enable self-reproduction. Understanding how biochemical path-
ways and regulatory circuits work together to achieve this
robustness remains an open problem with major implications for
systems and synthetic biology [4–7].
One approach to this question is to use genome-scale,
constraint-based models of metabolism (such as flux balance
analysis, FBA [8–11]). These models rely predominantly on
reaction network stoichiometry to provide a scalable, largely
parameter-free method for linking individual reaction fluxes with
global cellular properties, such as growth. Importantly, constraint-
based models frequently assume that the cell has been optimized,
through selective pressure and evolution, towards some cellular
objective (frequently captured in the biomass flux). The major
drawbacks of constraint-based approaches (in contrast to mech-
anistic models of metabolism [12]) are the incapacity to predict
metabolite concentrations and the difficulty of making inferences
about the dynamics of the system, though recent efforts have made
important contributions in overcoming some of these limitations
[13,14].
Here, we show that some features of the behavior of
intracellular metabolites are shaped by the interplay between the
stoichiometric architecture of the metabolic network and the
nutrient limitations imposed by environmental conditions, as well
as the key role of metabolism as the conduit for allocating cellular
resources towards growth. This link between structure and
function of metabolism is hidden in a largely unappreciated aspect
of the solution to flux balance models, namely the dual solution to
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the associated linear programming (LP) problem [15]. Our
main results are threefold. First, we demonstrate how
sensitivities to each steady-state constraint in FBA (referred
to as shadow prices, and often automatically calculated when
solving an FBA problem [16–19]) correlate negatively with
experimentally quantified degrees of growth-limitation of a
metabolite. Second, we show how the growth-limitation of a
metabolite (as captured by its shadow price) provides a
window onto the temporal response of that metabolite
following an environmental perturbation. In particular, by
examining a number of time-dependent metabolomics data-
sets, we observe that metabolites which have large negative
shadow prices also exhibit little temporal variability following
a perturbation. Third, we examine the broad applicability of
shadow prices to other constraint-based approaches to
modeling metabolism. We show that, by studying the shadow
prices of a constraint-based model that incorporates high-
throughput gene expression data, we are able to predict
whether an intracellular metabolite accumulates or depletes.
Taken together, our results suggest that shadow prices and
‘‘flux imbalance analysis’’ may find quite useful application in
probing the behavior of metabolites using constraint-based
modeling.
Results
Shifting the Focus from Fluxes to Metabolites: Shadow
Prices
Flux balance analysis is a method for computing expected
reaction rates in complex metabolic networks, and has been
described in detail elsewhere [9,20]. The basic strategy of FBA is
to identify steady state metabolic rates (fluxes) that satisfy a set of
constraints, and maximize (or minimize) a given objective
function. The main constraints are usually (i) mass conservation
(or flux balance) at each metabolite node, due to the steady state
approximation, and (ii) a set of inequalities associated with
limitation of extracellular metabolites and empirical evaluations
of irreversibility. Key inequalities are usually imposed on exchange
reactions, i.e. source/sink reactions mediating the interaction
between a cell and its surrounding environment. A canonical
FBA calculation can be formally expressed as the following primal
LP problem:
Maximize Z~
Xn
j~1
cjvj ð1Þ
Subject to
Xn
j~1
Sijvj~bi Vi~1, . . .m ð2Þ
vLBj ƒvjƒv
UB
j Vj~1, . . . n ð3Þ
where S is the m (metabolites) by n (reactions) stoichiometric
matrix, v is the vector of metabolic fluxes, vLB is a vector of lower
bounds for all fluxes, vUB is a vector of upper bounds for all fluxes,
b is the vector of the rates of accumulation/depletion of each
metabolite, and c is the vector defining the contribution of
different fluxes to the objective function.
For intracellular reactions, the right-hand-side coefficients bi in
Eq. (2) are typically assumed to be zero, capturing the assumption
that all intracellular metabolites are at steady state. Our analysis is
essentially centered on exploring how the cell would respond to
deviations from null bi coefficients. Such a deviation implies a flux
imbalance at metabolite i, and hence its accumulation or
depletion. Importantly, this interpretation of Eq. (2) is not meant
as a substitute for the underlying kinetics of the system. Such a flux
imbalance may propagate through the metabolic network to
influence the optimal value of the objective function Z. How can
one quantify the sensitivity of the objective function to such flux
imbalances? What is the biological significance of these sensitiv-
ities?
In fact, every LP calculation can be reformulated in terms of a
complementary problem known as the dual problem [15],
whose variables (referred to as a shadow prices, li) specifically
capture the change in the value of the objective function upon a
unit change in the right-hand-side of a single constraint (bi). The
general formulation of the dual problem can be found in any
linear optimization textbook (e.g. [15]), and its specific
formulation for FBA is described in detail in the Methods
section. In practice, the shadow prices are typically provided in
parallel to the primal variables by any LP solver upon solving
Eqs. (1)–(3).
In analogy with the interpretation of shadow prices in
economics and in line with prior work on shadow prices in
constraint-based metabolic modeling [16–19], FBA’s shadow
prices estimate the value of each metabolite to the global
molecular budget of a growing cell (Figure 1). The interpreta-
tion of shadow prices is particularly interesting in the case of the
canonical FBA objective function, i.e. maximization of the
biomass flux (Z= vgrowth). In this case, a shadow price corre-
sponds to the change in the biomass flux when one of the
intracellular metabolites deviates from steady state. Importantly,
if a metabolite has a negative shadow price, this means that
allowing additional outflow from this metabolite (so that bi,0)
will increase the maximal value of the biomass flux, implying
that this metabolite is limiting for the biomass objective (Figure 1).
In the remainder of this article, we test the hypothesis that
shadow prices correlate with the magnitude of growth-limitation
of a metabolite using experimental data, and explore the
broader implications of shadow prices in modeling genome-scale
metabolism.
Author Summary
Cellular metabolism is composed of a complex network of
biochemical reactions that convert environmental nutri-
ents into biosynthetic building blocks and energetic
currency. Genome-scale mathematical models of metabol-
ic networks focus largely on trying to predict the rates – or
fluxes - of these reactions. By assuming that the
concentrations of intracellular metabolites are at steady-
state (flux balance), and invoking optimality, these
constraint-based methods for modeling metabolism have
offered abundant insight into how metabolic flux is routed
through the cell. Here we ask how cellular growth would
respond to deviations from steady state (flux imbalance) of
every possible intracellular metabolite. This question can
be addressed through a sensitivity analysis inherent to
linear optimization theory, known as duality. We show how
some features of metabolite concentrations, such as their
growth-limitation and their transient response, are cap-
tured by this sensitivity analysis. Our results suggest that,
in addition to predicting fluxes, stoichiometric models
offer a valuable route towards probing the metabolites
themselves and their relevance to growth dynamics.
Flux Imbalance Analysis
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Shadow Prices and Growth Limitation
To explore the connection between shadow prices and growth
limitation, we analyzed previously collected experimental data
studying the relationship between intracellular metabolite abun-
dances and growth-limitation in Saccharomyces cerevisae under
continuous culture [21]. For three different conditions (single
nutrient limitation on glucose, nitrogen, and phosphate), and two
auxotrophic mutants (leucine and uracil) the abundance of
intracellular metabolites was quantified for several different
dilution (growth) rates.
Boer and colleagues [21] showed that the growth limitation of a
metabolite could be quantified by measuring the change in
metabolite abundance at different, increasing growth rates. In
particular, metabolites with relatively low intracellular concentra-
tions which increased in abundance as growth rate increased were
found to be growth-limiting. In contrast, metabolites which relatively
high concentration and which decreased in concentration as growth
rate increased were described as ‘‘overflow’’ metabolites, and were
not growth-limiting. To understand why we may expect such
correlations, we can re-elaborate on the reasoning presented by
Boer and colleagues in [21]. As described in [21], we consider the
simplest case, where growth is limited by the concentration of a
single, growth-limiting nutrient M. The dependence of growth on
this metabolite can be described by the classical Monod equation:
m~
mmaxM
KzM
where K is the half-saturation constant, m is the growth rate, and
mmax is the maximum growth rate. As we derive in detail in
Supplementary Text S1, valuable intuition for the dependence of
m on M can be gained by considering the limiting cases M..K
and M,,K. In the first case, M is substantially larger than the
half-saturation constant K. Then, the growth rate is relatively
insensitive to changes in M, and it can be treated as non-growth-
limiting. By calculating the dependence of M on m in this limiting
case, one finds
d log
m
mmax
 
d logM
&
K
M
&0
Thus, in this case, we would expect very small correlation between
log m and log M. As shown in [21] this correlation can even
become negative due to feedback inhibition (corresponding to
points below the horizontal red line in Figure 2). In the other
limiting case, where M is much smaller than K (and the growth
rate is very sensitive to M, so M is very growth-limiting)
d log
m
mmax
 
d logM
&1
and we expect a positive correlation between m and M
(corresponding to points above the horizontal red line in
Figure 2). The extent of this correlation (together with its sign),
constitutes a metabolite-specific metric for growth limitation, and
corresponds to the abscissa in the graph of Figure 2. Furthermore,
this simple model is readily extendible to cases where many
metabolites may simultaneously be limiting for growth rate, as
shown in [21].
We compared the growth-limitation measurements for each
metabolite identified as significantly growth-limiting or non-
growth-limiting/overflow in [21], to the corresponding shadow
prices computed through FBA in silico experiments when
maximizing for biomass production in the yeast model iMM904
[22]. For all natural nutrient limitations, we found an antic-
orrelation between shadow prices and growth-limitation: growth-
limiting metabolites exhibit negative shadow prices, while non-
growth-limiting metabolites exhibit small or zero shadow prices
(Figure 2). Furthermore, for each individual nutrient condition, the
more negative a shadow price was, the more limiting the
corresponding metabolite was found to be in the original paper
[21]. Although there is little support that the correlation between
shadow prices and growth limitation is linear, we report both
Spearman (rank-based) and Pearson (linear) correlations. These
anticorrelations were strongest for nitrogen (Spearman r=20.74,
p-value = 261025, Pearson r=20.77, p-value = 161025) and
phosphate limitation (Spearman r=20.66, p-value = 561025,
Pearson r=20.50, p-value = 0.033), where there were substan-
tially more data points (12 and 17 metabolites experimentally
identified as significantly growth- or non-growth-limiting in [21],
respectively) than for glucose limitation (Spearman r=20.59, p-
value = 0.008, Pearson r=20.77, p-value = 161025, 7 metabolites).
In agreement with [21], the growth-limiting metabolites in each
condition reflect the corresponding nutrient limitation. In nitrogen
limitation, we found many candidate growth-limiting metabolites,
nearly all of which were amino acids. In glucose starvation, we
found N-acetyl-glucosamine-1-phosphate (a precursor for protein
glycosylation) and arginine to be among the most growth-limiting
metabolites (with the most negative shadow price). The main
outlier in glucose starvation was glutamate, which had a negative
shadow price (i.e. predicted to be growth-limiting) even though its
concentration was experimentally observed to fall with increasing
Figure 1. Shadow prices in FBA capture the sensitivity of
growth to flux imbalances. Consider the FBA problem with one
metabo l i te and two react ions , fo rmula ted as : max v2 ,
Subject to v1{v2~0; 0ƒv1ƒv1,max; 0ƒv2ƒv2,max. The solid red line
indicates the feasible solution space, and the red dot indicates the
optimal solution. When the flux balance condition is relaxed and the
outgoing flux fromM is allowed to increase, the feasible space moves to
the right (dashed blue line) and the optimal solution increases. Since
the objective function increases as the right-hand-side of the flux
balance constraint decreases, the metabolite has a negative shadow
price. In general for intracellular metabolites, negative shadow prices
correspond to growth-limiting metabolites.
doi:10.1371/journal.pcbi.1003195.g001
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growth rate. The authors of [21] attributed this peculiar behavior
of glutamate to the potential overabundance of nitrogen relative to
carbon in extremely carbon-limited environments. Perhaps most
interestingly, we found that the largest shadow prices occurred
under phosphate limitation (see Figure 2, green dots), in
agreement with the large growth-limitation (in comparison to
other conditions) reported in [21]. It will be interesting in the
future to investigate whether the apparent strength of growth-
limitation (as quantified by the magnitude of the shadow price)
plays a role in the extent to which these metabolites regulate the
rates of enzymatic reactions.
We repeated the statistical analyses above for two ‘‘lumped’’
datasets containing data from (i) all three natural nutrient
limitation conditions (glucose, nitrogen, and phosphate limitation;
Spearman r=20.87, p-value 261028, Pearson r=20.69, p-
value = 861025) and (ii) all three nutrient limitation conditions,
together with auxotrophies (Spearman r=20.70, p-val-
ue = 2610213, Pearson r=20.28, p-value = 0.006). The results
also remained valid when we only considered cytosolic metabo-
lites, rather than metabolites from all compartments (see Table S1
and Dataset S1). Finally, we assessed whether the sign of a shadow
price (i.e. either zero or negative) could be used as a predictive
binary classifier for whether a metabolite is growth-limiting or
non-growth-limiting. To do so, we calculated the Matthews
Correlation Coefficient (MCC) [23], a standard measure for the
performance of a binary classifier. We found statistically significant
agreement between the sign of a shadow price and its classification
as growth-/non-growth-limiting, both when using metabolites
from all compartments (MCC 0.61, p-value = 561028) and only
cytosolic metabolites (MCC 0.81, p-value = 161027).
An important question in the above analysis, and in the
calculation of shadow prices in general, is whether the possible
alternative optima in the FBA optimization problem could give
rise to degenerate shadow prices, and hence ambiguity in the
comparison with experimental data. As described in detail in the
Methods, we addressed this issue by recalculating each shadow
Figure 2. Shadow prices anticorrelate with experimental measurements of growth limitation. Metabolites exhibiting
d logMð Þ=d logmð Þw0 were experimentally determined to be growth-limiting. Growth-limitation d logMð Þ=d logmð Þð Þ and shadow prices in FBA
are significantly anticorrelated under all nutrient limitations from [21]. To make the data more comparable across different nutrient limitations, the
data is plotted on a log scale. All points to the left of the grey bar have a shadow price of zero. All correlations for this data (calculated using a linear
scale, not the log scale depicted in the Figure) are reported in Table S1. Abbreviations: 6PDG, 6-phospho-d-gluconate; ADE, Adenosine; ALA, Alanine;
ARG, Arginine; ATP, ATP; CHO, Choline; CTP, CTP; CYD, Cytidine; CYT, Cytosine; DHAP, Dihydroxyacetone-Phosphate; DOG, Deoxyguanosine; DS7P, D-
sedoheptulose-7-phosphate; F16P, Fructose-1,6-bisphosphate; GLN, Glutamine; GLU, Glutamate; GUA, Guanosine; HIS, Histidine; INO, Inosine; LEU,
Leucine/isoleucine; LYS, Lysine; NAD, NAD+; NAG1P, N-acetyl-glucosamine-1-phosphate; NIC, Nicotinate; ORN, Ornithine; PHP, Phenylpyruvate; PYR,
Pyruvate; RIBP, Ribose-phosphate; SER, Serine; SUC, Sucrose; THR, Threonine; TRE, Trehalose; TRP, Tryptophan; UDPG, UDP-D-glucose; UTP, UTP. For
clarity, only cytosolic metabolites from the metabolic model are plotted.
doi:10.1371/journal.pcbi.1003195.g002
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price in a brute force way, i.e. by solving two additional LP
problems where the right-hand-side of each steady-state constraint
(bi in Eq. (2)) is incremented/decremented by a small amount (as
explored before in a different context [24] and in detail in the
Methods). The shadow prices obtained from solving these two
problems correspond to manual (i.e. not obtained automatically
from the LP solver upon solving the primal) re-calculations of the
sensitivity of the objective function to deviations from each steady-
state constraint. We then compared the incremental shadow price,
decremental shadow price, and the shadow price obtained directly
from the LP solver, and found no instances of degeneracy in our
shadow price calculations.
Our results so far indicate, in line with our intuition and with
prior work on duality in FBA [17,18], that shadow prices may
serve as quantitative measures of the sensitivity of growth rate to
the abundance of an intracellular metabolite. In the next section,
we investigate whether this sensitivity has implications for the
transient dynamics of growth-limiting metabolites following a
perturbation.
Shadow Prices and Metabolic Dynamics
Given the metabolite-specific associations between shadow
prices and growth-limitation, we decided to investigate whether
shadow prices could also aid in understanding other features of
intracellular metabolites. In particular, we reasoned that if a
metabolite is truly growth-limiting, then its concentration in the
cell should be tightly controlled. If, in contrast, a growth-limiting
metabolite’s concentration is allowed to fluctuate or vary
uncontrollably, this temporal variability would eventually propa-
gate to growth rate and have potentially deleterious consequences.
Our reasoning was further bolstered by recent studies of the
metabolic response of Escherichia coli to sudden perturbations which
demonstrated that the growth rate of cells responds remarkably
quickly to changes in environmental conditions. In two experi-
ments [25,26], it was shown that a sudden change in substrate
availability in the environmental media led to a rapid change in
the growth rate. In [25], a pulse of glucose to a glucose-limited
chemostat culture of E. coli lead to a 3.7-fold increase in growth
rate less than a minute. Similar results were observed in [26] for
pulses of pyruvate and succinate.
Based on our reasoning and on the two studies in [25,26], we
hypothesized that growth-limiting metabolites (with very negative
shadow prices) should exhibit very little temporal variation in their
concentrations in response to perturbations. In contrast, metab-
olites exhibiting large temporal variation should not be growth-
limiting (and have small or zero shadow price). We tested this
prediction using multiple time-course metabolomics datasets for E.
coli for different glucose and nitrogen perturbations [27,28]. We
elected to use these datasets because they contained information
for a large number of metabolites (,70 unique compounds),
enabling us to obtain reasonable statistical power. For each
dataset, we calculated the temporal variation of a metabolite
across the time course following the perturbation, using the
coefficient of variation (CV, the standard deviation of the time
series, divided by its mean; see Methods for more details). Thus, a
very large temporal variation corresponded to a circumstance
when a metabolite’s concentration changed substantially following
a perturbation, and a small temporal variation indicated that a
metabolite’s concentration remained relatively constant post-
perturbation. After calculating the temporal variation for each
metabolite, we computed the metabolite shadow prices using FBA
(see Methods).
The results of our analysis are shown in Figure 3. In agreement
with our expectations, shadow prices were found to be correlated
with temporal variation in the five perturbations we studied.
Metabolites with very large, negative shadow prices (and thus very
limiting for biomass production) showed little temporal variation.
Conversely, metabolites with the largest temporal variation were
found to have comparatively smaller shadow prices. We again
report both Spearman and Pearson correlations, although there is
no a priori reason to expect linear correlations. The correlations
were statistically significant for nitrogen upshift (Spearman
r= 0.26, p-value = 0.02, Pearson r= 0.22, p-value = 0.04), as well
as the 4 different carbon perturbations (glucose starvation,
Spearman r= 0.21, p-value = 0.05, Pearson r= 0.21, p-value =
0.045; acetate limitation, Spearman r= 0.37, p-value = 0.002,
Pearson r= 0.36, p-value = 0.002; succinate limitation, Spearman
r= 0.23, p-value = 0.04, Pearson r= 0.18, p-value = 0.08, and
glycerol limitation, Spearman r= 0.32, p-value = 0.007, Pearson
r= 0.33, p-value = 0.006). These correlations were further sub-
stantiated using non-parametric permutation tests, described in the
Methods, with results detailed in Table S2.
Despite these statistically significant correlations, a number of
outliers (i.e., metabolites with relatively large, negative shadow
prices and high temporal variation) appeared in our results.
Among the outliers under glucose limitation (Figure 3B), the most
notable were cyclic AMP (a signaling molecule) and acetyl-CoA.
More interestingly, in both acetate and glycerol limitation, a
repeated outlier was fructose 1,6-bisphosphate (FBP). This
metabolite was highlighted in one of the two papers from which
we obtained the time-series data [28]. As the authors showed
there, upon a sudden switch from glucose medium to either no
carbon, acetate, succinate, or glycerol, the concentration of FBP
dropped suddenly by 15- to 30-fold. This sudden drop in FBP,
coupled with its role as an allosteric activator of PEP carboxylase,
resulted in the buildup of PEP. This buildup enabled fast uptake of
glucose when it re-appears in the media, where it is used as a
phosphate donor for the import of glucose. Furthermore, FBP was
recently identified as a candidate ‘‘flux sensor,’’ i.e. a metabolite
whose concentration may change in linear proportion to the flux
through glycolysis, via its role as an activator of pyruvate kinase
[29]. Thus, the aberrant behavior of FBP (a negative shadow
price, but high temporal variation) may be related to its key role in
affecting E. coli’s response to glucose starvation and carbon
limitation through allosteric regulation.
To further corroborate our findings, we tested whether the
differential dynamic behavior of mutant knockout strains could be
captured through our analysis. We used additional metabolite time
series available for the wild type and two knockout strains
(DGOGAT and DGDH) of E. coli following nitrogen upshift in
[27]. We replicated these knockouts in silico, and calculated the
shadow prices. We performed two different analyses on this
dataset: first, we looked broadly at the changes in shadow prices
(from wild-type to knockout) for each of the two knockouts. As
illustrated in Figure 4, we found that for the DGOGAT strain, 22
metabolites showed a significant drop in shadow price, decreasing
by a magnitude greater than one (i.e. becoming more growth-
limiting). The most drastic changes were found for lipids and
precursors, like undecaprenyl phosphate, and UDP-D-glucoro-
nate, both of which showed a drop in shadow price of 1.29. In
contrast, the DGDH knockout featured no metabolites with a
substantial (greater than 0.1) drop in shadow price. This absence
of new growth-limiting metabolites in DGDH is consistent with the
observation in [27] that the GS/GOGAT pathway dominates
over GDH in nitrogen limitation. Interestingly, a subset of eight
metabolites, all corresponding to glycolipids, showed a substantial
increase in shadow price in DGDH (corresponding to a relaxation in
growth-limitation). Thus, while the ‘‘growth-limitation landscape’’
Flux Imbalance Analysis
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of the DGDH mutant, characterized by the most growth-limiting
metabolites in the model, seemed relatively similar to that of the
wild-type, the DGOGAT strain displayed substantially different
growth limitations.
Second, we tried to recapitulate the primary qualitative finding
of the knockout study from [27]: that glutamine exhibited a
substantial drop in temporal variation in DGOGAT in compar-
ison to the wild-type and DGDH strains (from a sudden increase
and then return to steady state in wild type and DGDH strains to
nearly no response in DGOGAT). When comparing the shadow
prices of glutamine across the different strains, the shadow price of
glutamine dropped from 0 to 20.08, in both DGDH and
DGOGAT. While the shadow prices of other metabolites tracked
in the knockout experiments changed as well, glutamine exhibited
the largest drop. Thus, despite the fact that an alternative pathway
for nitrogen assimilation was present in each knockout strain, the
knockout of either GDH or GOGAT led to an increase in growth-
limitation of glutamine. This drop in shadow price was in
qualitative agreement with the experimentally observed drop in
temporal variation in the knockout strains (from 0.85 in wild-type
to 0.78 in DGDH and 0.32 in DGOGAT).
Figure 3. Shadow prices correlate with temporal variation in metabolite abundance in E. coli. The height of each bar represents the
number of individual metabolites that fall within a bin. Boundaries between the blue and red regions in each panel correspond to the mean values of
shadow prices and temporal variation, respectively. We expect that metabolites with negative shadow prices should have small temporal variation,
while metabolites with large temporal variation should have small or zero shadow prices (gray regions). Furthermore, metabolites should not exhibit
large temporal variation if they have large negative shadow prices (red region). Bars tend not to fall in the red regions (as quantified statistically, see
reported p-values, Table S2) highlighting the capacity of shadow prices to capture features of metabolite dynamics. Subplots correspond to different
experimental conditions: (A) nitrogen upshift (B) glucose starvation, (C) acetate limitation, and (D) glycerol limitation.
doi:10.1371/journal.pcbi.1003195.g003
Figure 4. FBA shadow price analysis in knockout strains.
Changes in shadow price between the wild-type strain and two
knockout strains in E. coli following nitrogen upshift. In comparison to
the wild-type, only the DGOGAT contains any metabolites which are
substantially more growth-limiting.
doi:10.1371/journal.pcbi.1003195.g004
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Thus, the shadow prices associated with individual intracellular
metabolites provide information not only about the extent to
which each metabolite is limiting for growth, but also about its
overall temporal variation following a perturbation. Importantly,
in the current framework, shadow prices do not provide
quantitative predictions about the speed at which metabolites
respond, or the new steady-state concentrations they reach.
Hence, shadow price analysis should not be treated as a substitute
to explicit predictions from kinetics. While our results seem to hold
across different experiments in E. coli (i.e. different nutrient
limitations and genetic modifications, albeit in a noisy manner), its
general validity and mechanistic basis across different organisms
and types of perturbations will require further scrutiny and will be
an important aspect of future work. In particular, the availability
of specific mechanistic models for the metabolic response to
perturbations, coupled with higher temporal resolution data,
would allow one to obtain more precise estimates of temporal
variability, and hence better quantitative comparisons with
shadow prices.
Shadow Prices and Gene Expression Data
So far, we have corroborated the notion that shadow prices are
indicative of growth limitation, and demonstrated that shadow
prices are even more broadly related to metabolite dynamic
variability. As described above and in the Methods, shadow prices
are dependent on the underlying stoichiometric model, and the
specific environmental conditions. Correspondingly, in the analysis
shown up to now, we have explored the relevance of shadow prices
across different conditions (different nutrient limitations and
genetic modifications). There is, however, a third feature that
shadow prices crucially depend on, i.e. the specific objective
function used in the FBA optimization. Does the analysis of
shadow prices have a meaning and an application for stoichio-
metric problems with radically different objective functions, or is it
biologically interpretable only for the growth maximization
objective? To answer this question, we decided to explore the
significance of shadow prices in a recently proposed optimization
problem aimed at identifying genome-scale fluxes that minimize
the inconsistency relative to a given set of gene expression data.
This approach, pioneered with the GIMME algorithm [30], and
recently re-elaborated in the time-dependent TEAM method [31],
is a way of integrating gene expression data with stoichiometric
models of metabolism, in order to obtain better predictions and
understanding of cellular physiology. Instead of maximizing
growth, GIMME and TEAM minimize the conflict between gene
expression data and flux predictions using a penalty score (see
Methods). In particular, fluxes whose corresponding gene(s)
exhibit low expression are penalized (Figure 5A) in proportion to
how much lower the gene expression is, relative to a given gene-
specific threshold (see [31] and Methods). The cumulative penalty
obtained from all these costs (termed the Inconsistency Score, IS) is
minimized across the entire metabolic network [30,31]. This
problem can be solved again using linear programming, in analogy
to the FBA problem illustrated above:
Minimize IS~
Xn
j~1
cj vj
  ð4Þ
Subject to
Xn
j~1
Sijvj~bi Vi~1, . . .m ð5Þ
vLBj §vjƒv
UB
j Vj~1, . . . n ð6Þ
vRMF§vRMF ,min ð7Þ
where c is a vector of reaction penalties, and the reaction flux vRMF
is a required metabolic functionality (RMF), some minimal, user-defined
metabolic behavior which the model must reproduce (for example,
growth at a minimal rate or the secretion of a metabolite). One of
Figure 5. In a constraint-based method that integrates gene
expression (GIMME/TEAM), shadow prices predict the direc-
tion of changes in metabolite abundance. (A) Schematic of the
GIMME/TEAM algorithm. Enzymes whose constituent genes show very
low expression (red) are penalized. Then, a flux distribution is identified
with the lowest total penalty (in this case, the alternative pathway with
high expression, colored in green). (B) Schematic of the interpretation
of shadow prices in TEAM. Consider a situation in which, at steady-state,
a reaction with low gene expression (red, high penalty) is inferred by
the model to carry a high flux, leading to a high penalty. When the
metabolite is allowed to deviate from steady-state by lowering the flux
through the highly penalized reaction, the penalty predicted by TEAM
falls. The shadow price lM for this metabolite, whose concentration is
predicted to be decreasing, is thus positive. (C) Shadow prices
predicted by TEAM and observed changes in metabolite abundance
are significantly negatively correlated. A threshold of h= 0.88 was used,
although other values of h yielded similar results (SI Figure S1). Changes
in metabolite abundance were calculated using measurements
between hours 10 and 11 in [33] where acetate was observed to be
secreted from the cell [32]. Expression data used as input to TEAM is
taken from hour 35 of [32]. Both time points correspond to the same
phase in the metabolic cycle of yeast, during the end of the oxidative
and beginning of the reductive/building phase.
doi:10.1371/journal.pcbi.1003195.g005
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the reasons the RMF constraint is imposed is to avoid the trivial
solution v= 0.
As depicted in Figure 5B, shadow prices in TEAM have a
different interpretation from shadow prices in FBA. A shadow
price in TEAM is defined as the change in the inconsistency score
IS when the steady-state constraint on one metabolite bi deviates from
zero. It is reasonable to assume that some portion of the
inconsistency between experimentally measured gene expres-
sion and TEAM’s flux predictions is the result of imposing the
steady state assumption in our model, while a metabolite may
be truly accumulating or depleting during certain time
intervals in the experiment. Allowing such a metabolite to
violate the flux balance condition (either accumulate or
deplete) should lower the inconsistency score. Then, if a
metabolite’s abundance is decreasing, we should expect the
shadow price to be positive (Shadow Price = negative change in
IS/negative change in abundance). Conversely, if the metab-
olite’s abundance is increasing, then we should expect the
shadow price to be negative (Shadow Price = negative change in
IS/positive change in abundance). As illustrated in Figure 5B,
TEAM’s shadow prices should thus be informative of the
direction of changes in metabolite abundance: metabolites
with positive (negative) shadow price are expected to decrease
(increase) in abundance.
To test whether TEAM’s shadow prices indeed could predict
changes in intracellular metabolite abundances, we re-analyzed a
transcriptomics [32] and metabolomics [33] dataset for the yeast
metabolic cycle, previously integrated in FBA using TEAM (see
[31]). Our analysis (see Methods for details) showed a significant
anticorrelation between TEAM’s shadow prices and experimen-
tally measured changes in metabolite abundance (Spearman
r=20.41, p-value = 961026; Pearson r 20.31, p-val-
ue = 861024; Figure 5C). Notably, if we only consider those
metabolites for which TEAM reported a nonzero shadow price,
we correctly identify the direction of change (e.g. increase or
decrease) in 55 of 63 metabolites in the dataset. We used this data
in combination with the Matthews Correlation Coefficient (used
earlier to analyze data from Figure 2) as a measure of how well the
sign of TEAM’s shadow prices can be used to predict the
accumulation/depletion of a metabolite. We found that the sign of
the shadow price was indeed a good predictor of the direction of
change of a metabolite’s concentration (MCC 0.68, p-value
761028). Interestingly, among the incorrect predictions, many
were for amino acids (methionine, ornithine, proline). The failure
of TEAM’s shadow prices to predict changes in abundance for
these compounds suggests that inconsistency with gene-expression
data in pathways utilizing these metabolites may not be due to flux
imbalances, and may instead indicate that other regulatory
mechanisms are at play.
Using the same sensitivity analysis developed in [31] and
discussed in the Methods, we furthermore confirmed that the
shadow price results reported above were insensitive to changes
of the primary free parameter of TEAM, h (a measure for how
high to set each gene’s penalty threshold), within the range
h= 0.50–0.73 and h= 0.78–0.88. This range of thresholds is
substantially larger than the range of h’s found to accurately
recapitulate experimental data in our studies of Shewanella
oneidensis using TEAM (h= 0.65 to h= 0.72) [31], suggesting
our results here are robust to variations in h. Thus, our analysis
of flux imbalances in TEAM, a constraint-based approach
based on an objective function radically different from the
classical growth maximization of FBA, reveals that shadow
prices have useful applications beyond conventional flux
balance methods.
Discussion
Constraint-based stoichiometric models of metabolism have
become a widely used approach for characterizing and predicting
cellular metabolic states [10]. The notion that steady-state
constraints and a cell-level objective function provide an approx-
imate quantitative understanding of the behavior of a population
of cells has been subjected to experimental testing, and discussed at
length in the literature [8,11,34]. Yet, other more subtle aspects of
stoichiometric modeling, such as the potential power of shadow
prices, had not been directly tested. Nor had the idea of flux
imbalance been pursued as a link between the sensitivity analysis
of FBA and the dynamics of metabolite pools.
The results we have presented may seem at first glance
surprising. How can a steady state solution convey information
about the dynamical changes of metabolite pools? The answer is
that flux balance models are not simply steady state solutions to a
dynamical system. Rather, they use constraints and optimality to
predict how a cell should allocate its resources for maximal
efficiency, given the underlying network architecture. It would be
tempting to make the leap of inferring that the architecture itself
truly constrains the dynamics, independent of parameters and
regulation. Rather, we suggest that the stoichiometric architecture
may dictate how regulation should evolve to guarantee robustness
to temporary variations in the intracellular milieu. If the cell
cannot allow itself to accumulate or deplete certain metabolites,
without incurring a substantial penalty to growth, then the
response to variations in these metabolite pools should be swift.
This suggests that quick allosteric and post-translational metabo-
lite-induced regulatory feedback should control the stability of
these pools [35,36] and highlights the role the growth process itself
may play in providing immediate feedback on metabolite pools by
virtue of growth limitation [37]. Thus, we expect that an
important challenge for future work will be examining our
findings in light of newly reconstructed atlases of metabolic
regulatory mechanisms [36].
A subtle but potentially important aspect of shadow prices and
their biological interpretation in metabolic network models is the
fact that they are defined only over a certain range, as dictated by
the structure of the feasible space. These ranges capture how large
a perturbation can be before the genome-scale optimal flux
distribution changes sharply (i.e. by moving to a different corner of
the feasible space). In future research, it would be interesting to
directly assess the potential existence of such discontinuities in the
dynamical behavior of a perturbed metabolic network. In
addition, the magnitude of the range of validity of a shadow price
may be thought of as an additional tolerance metric for each
individual metabolite, conveying the scale beyond which its
response to a perturbation becomes unpredictable. Future models
may test whether the extent to which a metabolite is regulated
depends both on its shadow price, as well as this tolerance to large
perturbations.
The sensitivity of cells to variations in specific metabolite pools
suggests a novel, metabolite-centric route towards the computa-
tional prediction of drug targets, e.g. for selectively affecting
microbial pathogens or cancer cells. In addition to seeking enzyme
gene deletions as a way to impair specific metabolic pathways [38],
one could instead impair the regulatory mechanism stabilizing
metabolite pools to which growth is particularly sensitive. Notably,
the shadow prices automatically generated upon solving the FBA
problem would directly provide a prioritization list of the most
sensitive target metabolites. It will be interesting to relate the
metabolite-centric information obtained from shadow prices to
prior quantifications of the importance of metabolites based on
Flux Imbalance Analysis
PLOS Computational Biology | www.ploscompbiol.org 8 August 2013 | Volume 9 | Issue 8 | e1003195
their producibility upon gene deletions [39] and on the sum of
all incoming or outgoing fluxes around them [40]. Furthermore,
one could consider how lethal gene deletions/perturbations,
which often result in infeasible models for which shadow prices
are not immediately available, can be treated using our
framework.
Another prospect for future studies will be to evaluate
whether shadow prices may shed light on the interplay
between evolution, regulation, and the sub-optimal behavior
of cells. While most stoichiometric models still use maximi-
zation of growth as the central objective, a number of studies
have suggested specific applications of alternative objectives.
These include the Minimization Of Metabolic Adjustment
[41] (or its recent more robust variant, Minimization of
Metabolites Balance [42], based on metabolite turnovers
instead of fluxes) for describing the cellular phenotypes arising
upon genetic perturbations prior to further regulatory or
evolutionary optimization, and multi-objective Pareto optimal-
ity for studying how cells may sacrifice optimal growth in
favor of tradeoff solutions [43]. In the same spirit as our ad
hoc interpretation and analysis of TEAM’s shadow prices,
sensitivity of these optimization problems to their respective
constraints may offer further insights into the cellular response
to perturbations.
Additionally, upon availability of comprehensive data on
intracellular metabolite concentrations at multiple time steps,
one could envisage implementing stoichiometric models that use
explicit flux imbalances (rates of accumulation/depletion) as
inputs to the constraint-based model. For example, our shadow
price analysis with TEAM is readily extendible to cases where
the rate of accumulation/depletion is known for one subset of
metabolites, but unknown for another set (e.g. for metabolites for
which precise intracellular measurements are technically diffi-
cult). In such circumstances, for every metabolite for which
appropriate data is available, the right-hand-side of the
corresponding steady-state constraint (e.g. bi) could be adjusted
accordingly.
Finally, while the notion of flux imbalance analysis is not the
first to bridge between the worlds of stoichiometry and metabolic
dynamics [14,44], it is the first to use a genome-scale modeling
approach to make inferences about the qualitative response of
metabolite concentrations to a perturbation. We do not know the
mechanism which induces relatively fast changes in growth-
limiting metabolites, when compared to non-growth-limiting
metabolites. Indeed, an exciting prospect for future work will be
bridging our findings with well-established schools of metabolic
theory, including metabolic control analysis [44], biochemical
systems theory [45], and structural kinetic modeling [46,47].
Compellingly, the dual of the FBA problem has also been
suggested to constitute a window onto the thermodynamics of
biochemical networks, with potential implications for understand-
ing the energetics of metabolism [19]. Unifying these distinct
threads, which independently derive dynamic and energetic
meaning from the same mathematical framework, seems a
worthwhile direction for future efforts.
Methods
The Dual Problem to FBA and Shadow Prices
We offer here a simple derivation of the dual problem to flux
balance analysis. We begin by posing the primal FBA problem
Maximize Z~cTv ð8Þ
Subject to Sv~0
vLB§v§vLB
where c, v, vLB, and vUB are vectors of length n, and S is the m6n
stoichiometric matrix. For clarity and in contrast to the main text,
we have formulated the FBA problem in vector notation (including
inequalities, to be interpreted component-wise). We associate with
each set of constraints in the primal problem a single set of dual
variables. For the steady state constraints, we assign variables l (a
vector of length m, the shadow prices which we use throughout this
work), for the constraints on the lower bounds of each flux, we
assign variables q1 (a vector of length n), and for the constraints on
the upper bounds of each flux, we assign variables q2 (a vector of
length n). Then, following any standard text on linear optimization
(e.g. [15]) one can obtain from Eq. (8) the dual problem
Minimize q1
TvLBzq2
TvUB ð9Þ
Subject to cT~lTSzq1
Tzq2
T
q1ƒ0,q2§0
Alternate and Degenerate Shadow Prices
We implemented a number of measures to ensure that each
shadow price used in our calculations was accurate and
meaningful. In particular, we validated that the shadow prices
obtained directly from the LP solver could not take on different
values depending on whether a metabolite was accumulating or
depleting (i.e. that the shadow price was not degenerate, described
below). To do so, we used brute-force techniques to validate that
each shadow price reported by the solver was indeed the sensitivity
of the objective function to each steady-state metabolite constraint.
This process thus simultaneously helped ensure that our results
were robust to alternative dual optima.
In addition to the primal solution (optimal fluxes), the Gurobi
LP solver provides the corresponding dual solution to the FBA
problem. The dual solution contains (i) the shadow price value
relative to each metabolite steady-state constraint and (ii) the
upper (G+) and lower (G2) bounds for which these shadow prices
are valid. These bounds indicate the maximum that the right hand
side of each constraint may be perturbed while still maintaining
the validity of each shadow price. First, we ensured that any
calculated shadow prices had non-zero ranges of validity
(range=G+2G2). Any shadow prices which did not exhibit a
minimal range erange = 10
26 were discarded. Other tested values of
erange in the range 10
23 to 1026 led to qualitatively identical
results.
Second, we ensured that alternate optimal solutions [48] did not
impact the dual solution. Prior work has reported that degenerate
solutions can lead to differences between the incremental shadow
price l+ (the change in the objective function when the right-hand-
side of a constraint is increased) and the decremental shadow price
l2 (the change in the objective function when the right-hand-side
of a constraint is decreased) [24]. To ensure that this did not affect
our shadow price calculations, we manually re-calculated the
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incremental and decremental shadow price for each metabolite for
which we had experimental concentration data (indexed by itest) in
the model using a perturbation procedure. This calculation was
implemented by solving the two following optimization problems,
in which the steady state constraint is positively or negatively
violated at each individual metabolite:
max Zhigh,i~vgrowth ð10Þ
Subject to Sv~b,
vLBƒvƒvUB
b~
0 i=itest
p:Gi
z i~itest

maxZlow,i~vgrowth ð11Þ
Subject to Sv~b,
vLBƒvƒvUB
b~
0 i=itest
p:Gi
{ i~itest

Here, the parameter p modulates how large we allow a steady-state
constraint to be violated, while remaining in the range [Gi
{, Gi
z]
(where the Gi are those defined above with reference to the range
of each shadow price). Thus, 0,p,1. We used p= 0.2, although
other choices of p yielded identical results (we tried p= 0.5 and
p= 0.9). Upon solving the above optimization problems, the
incremental and decremental shadow prices can be computed as
the changes in the objective relative to the changes in the right-
hand side terms, i.e., respectively:
lzi ~
Zhigh,i{Z
p:Gi
z ð12Þ
l{i ~
ZLow,i{Z
p:Gi
{ ð13Þ
where Z is the solution to the regular FBA problem (i.e. the one
without perturbations of the right-hand sides). We then ensured
that the shadow price obtained from the solver deviated from lzi
and l{i less than the error tolerance of the solver. In many cases,
one of Gi
{ or Gi
z was equal to zero (i.e. the shadow price was
only valid when perturbing in one direction). In these cases, we
only manually calculated the shadow price corresponding to the
valid direction. It is important to note that lzi and l
{
i are
obtained through brute-force re-calculation of the shadow prices
obtained directly from the solver. While they are laborious, they
enable us to ensure that degenerate solutions do not adversely
affect our results.
In order to facilitate the implementation of degeneracy checking
of shadow prices, we have provided the pseudocode below:
CHECK_DEGENERACY(S,LowerBound,UpperBound,Ob-
jective)
1 # Run FBA and obtain four outputs: the optimal flux vector, the
shadow prices for each metabolite, the incremental range over which each
shadow price is valid, the decremental range over which each shadow price is
valid, and the optimal value
2 [Flux SP SPUpRange SPDownRange OptVal] =Run_
FBA(S, LowerBound,UpperBound,Objective, RHSConstraints)
3 p = 0.5 # p can take value between 0 and 1
4 # For every metabolite, check for degeneracy in the shadow price of the
metabolite by changing one of the steady-state constraints from zero to a non-
zero value within the range of validity
5 for i = 1…number of metabolites
6 if SPUpRange(i) .0: # if we can perturb up
7 RHSConstraintsPlus = RHSConstraints # Use a tempo-
rary variable
8 RHSConstraintsPlus(i) = SPUpRange(i)*p # Change one
constraint
9 # NEXT: Solve FBA with new constraint (incremental shadow
price)
10 [FluxPlus SPPlus SPUpRangePlus SPDownRangePlus
OptValPlus] =Run_FBA(S, LowerBound,UpperBound,Objective,
RHSConstraintsPlus)
11 end #end if
12 if SPDownRange(i) ,0: # if we can perturb down
13 RHSConstraintsMinus = RHSConstraints;
14 RHSConstraintsMinus(i) = SPDownRange(i)*p;
15 # NEXT: Solve FBA with new constraint (decremental
shadow price)
16 [FluxMinus SPMinus SPUpRangeMinus SPDown-
RangeMinus OptValMinus] =Run_FBA(S, LowerBound,Upper-
Bound,Objective, RHSConstraintsMinus)
17 end # end if
18 # Compare manually calculated shadow prices (if they exist) to
solver’s
19 SPPlus(i) = (OptValPlus – OptVal)/SPPlusRange(i)*p
20 SPMinus(i) = (OptValMinus – OptVal)/SPMinusRan-
ge(i)*p
21 if |SPPlus(i) – SP(i)|.tolerance OR |SPMinus(i) –
SP(i)|.tolerance
22 return ERROR # There is a degenerate shadow price
23 end #end if
24 end # end for
Software for the Solution of the FBA Primal Problem
In this work, all optimization problems were solved using the
Gurobi optimization software [49] with an academic license. In all
FBA problems, the objective was the wild-type biomass reaction in
the most recent Escherichia coli metabolic model [50]. The yeast
model iMM904 [22] was used for all growth limitation and TEAM
simulations, with media formulations matching those described in
the original publications.
Calculation of Temporal Variation in Escherichia coli
For all simulations relating to E. coli, we used the metabolic
network reconstruction iJO1366 [50]. Growth medium composi-
tions for all experiments simulated with the model were obtained
from the corresponding experiment references. In all cases, the
medium was based on the minimal salts medium [51] with 10 mM
ammonium. For experiments from [28], we removed glucose from
the media formulations and replaced it with the appropriate
limiting carbon source.
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In order to calculate temporal variation of metabolite, we use
the coefficient of variation (CV):
CV~
s
m
where s is the standard deviation of the measurements and m is the
mean. For all experiments from both publications, we calculated
temporal variation using time points up to 30 minutes following
perturbation.
Permutation Test to Evaluate Significance of Correlation
between Shadow Prices and Temporal Variation
In the main text, we show that metabolites with large negative
shadow prices exhibit little temporal variation, and metabolites
with large temporal variation should exhibit small (or zero) shadow
price. To further corroborate the significance of the antic-
orrelation between shadow prices and temporal variation
illustrated in Figure 3, we completed a nonparametric permutation
test.
For each experiment, the vector of shadow prices (l) and vector
of temporal variation (CV) of each metabolite were calculated.
Then, the mean temporal variation (mT) and mean shadow price
(mS) for the experiment were determined using l and CV,
respectively. We then computed the number of metabolites,
poriginal, which exhibited a shadow price more negative than mS and
a temporal variation larger than mT. These metabolites served as a
proxy for the number of ‘‘incorrect’’ assignments made by our
model.
We generated 105 random permutations of l and CV. For each
permutation i, we calculated pi, the total number of metabolites
satisfying the two criteria described above (exhibited a shadow
price more negative than mS and a temporal variation larger than
mT). Then, we identified the proportion of permutations for which
pi,poriginal (i.e. the permuted data exhibited fewer incorrect
predictions than the real data), reported in Table S2. We repeated
these tests using medians instead of means, with data reported in
Table S2.
Calculation of the Penalty Vector c for TEAM
The penalty vector c quantifies the modeler’s expectation that a
reaction is metabolically active (that is, that it carries flux) to an
extent that depends on the expression of its constituent genes. The
c vector is calculated by assigning a penalty to each gene in the
metabolic model, and then propagating these penalties to the
reactions using the Boolean gene-to-reaction mapping provided in
the model iMM904 [22]. The higher the value of the penalty ci for
reaction i, the higher our confidence that the reaction is inactive.
In contrast, reactions with c= 0 are expected to be active and carry
flux. Importantly, each element of c is calculated using experi-
mental measurements of gene expression.
First, we describe how we assign a penalty to each gene g in the
metabolic model. Gene penalties are determined by comparing
the expression value of a gene with a predefined threshold. For
each gene g, we created a cumulative distribution function (CDF)
of all expression measurements for that gene (using all gene
expression data reported in [32]). Then, for a chosen percentile h
(in Figure 5C, we use h= .88), we use the CDF to calculate (for
each gene) the expression value corresponding to that percentile.
This was the gene’s penalty threshold xg. For the purposes of this
article, the primary difference between TEAM [31] and GIMME
(an algorithm upon which TEAM is based, see [30]) is that TEAM
assigns unique penalty thresholds to each gene in the metabolic
model, while GIMME assigns a common penalty threshold to each
gene. In [31], we showed that these gene-specific thresholds
substantially increase the accuracy of the algorithm.
Once the gene expression penalty thresholds have been
calculated, the penalty for each gene g, pg, is calculated:
pg~
xg{EXPg if xgwEXPg
0 otherwise

where EXPg is the expression of gene g. Thus, if a gene’s expression
is above the penalty threshold xg, that gene is assigned no penalty.
In contrast, if its expression is found to be below the threshold,
then its penalty is equal to the difference between the two. As
described in [31], we used the gene-to-reaction matrix provided in
the metabolic model to map the vector of gene penalties p to a
vector of reaction penalties c.
Calculation of RMF Flux in TEAM
An essential part of TEAM’s formulation is a user-defined
required metabolic functionality (RMF). The RMF is a metabolic
behavior (such as growth or the secretion of a metabolite) that
TEAM must reproduce. It was observed in [32] that the
population of yeast secreted acetate at the end of the oxidative
portion of the metabolic cycle. We recreated in silico the
environmental conditions of the experiments. We decided to use
acetate secretion as our RMF flux. To do so, we first used FBA to
identify the maximal amount of acetate that could be secreted by
solving the optimization problem
maxvRMF~vacetate ð14Þ
Subject to Sv~0
vLBƒvƒvUB
Then, the minimal RMF flux vRMF,min was set to some proportion p
of this maximal secretion rate. We used p = 0.3, although other
values of p yielded qualitatively similar results.
Comparing Time Points between Metabolomics and
Transcriptomics Data in TEAM
Because the metabolomics and transcriptomics measurements
were obtained from two distinct experiments in which the periods
of the cycles were significantly different (,8 hours vs. ,12 hours,
respectively), we used dissolved oxygen measurements (DO) (which
the authors of [32] repeatedly cited as representative of the
population’s location in the cycle) to align timepoints from the two
datasets. The experiments were otherwise comparable in terms of
conditions and phenomena observed. All metabolomics data is
represented in Figure 5C as fold changes.
Calculation of Shadow Prices and TEAM Sensitivity
Analysis
In order to validate whether the results using TEAM were
dependent on our choice of penalty threshold h, we applied a
sensitivity analysis identical to the one described in [31]. We
calculated the Spearman correlation for all possible percentile
thresholds h from h~1% to h~99% for the same expression and
metabolomics time points as those in Figure 5C.
As shown in Figure S1, we found a large range of thresholds for
which we obtained high accuracy and a significant correlation,
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confirming that our results were not highly sensitive to choice of
penalty threshold.
Supporting Information
Dataset S1 Supporting Data. Contains data associated with
the figures.
(XLSX)
Figure S1 TEAM’s shadow prices are predictive of
metabolomics measurements for a large range of
penalty thresholds. We evaluated the sensitivity of the
predictive power of TEAM’s shadow prices to the particular
choice of penalty threshold h. We calculated the Spearman
correlation between shadow prices and observed changes in
metabolite abundance for h= 1% to h= 99% . Expression data
(hour 35 of [32]) and metabolomics data (changes in abundance
between hours 10 and 11 in [33]) are identical to those in
Figure 5C. For a large part of parameter space we observe
significant correlations (p-value,0.05, corresponding to points
below dashed line in bottom panel).
(TIF)
Table S1 Correlations between shadow prices and
measures of growth-limitation from [21]. For lumped
datasets (e.g. ‘‘All Conditions’’) we use non-normalized shadow
prices (as in the main part of Figure 1). Note that in the top set of
correlations, many metabolites (e.g. ATP) exist in several
compartments, and the shadow prices in each compartment were
used in the statistical test. While in most cases the shadow prices
across compartments were identical, there were several instances
where this was not the case (see Dataset S1 for data).
(DOCX)
Table S2 Results of permutation testing of shadow
prices and temporal variation. For all experimental
conditions, fewer than 5% of permuted shadow prices exhibited
fewer incorrect predictions than the true shadow prices.
(DOCX)
Text S1 Supporting Text. Contains additional details for the
calculations presented in the text.
(DOCX)
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